Skip to content
drillr.ai
Sign up

GSK

GSK Plc

NYSE · Healthcare · Drug Manufacturers - General · GB

Also listed · GSK.GB →
$49.46
−0.10%
Ask drillr

  • Oct 19, 2026, 06:39 UTC

    GSK plc reported early-stage trial results for risvutatug rezetecan, with confirmed responses in 11 of 18 patients at 8 mg/kg and seven of 22 patients at 6 mg/kg.

    Source:

  • Oct 18, 2026, 22:22 UTC

    GSK plc reported that its B7-H3-targeted antibody-drug conjugate Ris-Rez achieved a 61% objective response rate in a lung cancer clinical trial.

    Source:

  • Oct 15, 2026, 01:44 UTC

    Chia Tai Tianqing said its strategic-cooperation product Bepirovirsen was selected for two oral presentations and eight poster presentations at the 2026 AASLD annual meeting.

    Source:

  • Oct 14, 2026, 11:38 UTC

    Belgian Prime Minister Bart De Wever is set to meet GSK plc and its employees to discuss a restructuring plan.

    Source:

  • Oct 14, 2026, 08:18 UTC

    GSK plc informed Belgian unions of a proposed workforce reduction expected to affect 1,217 positions, including 735 management and 482 administrative roles.

    Source:

  • Oct 9, 2026, 18:10 UTC

    GSK plc is expanding its facility in Upper Merion Township, Pennsylvania, with construction planned to begin in 2027.

    Source:

  • Oct 9, 2026, 18:09 UTC

    GSK plc plans to invest more than $800 million in Pennsylvania to expand operations and create over 300 jobs.

    Source:

  • Oct 9, 2026, 12:01 UTC

    Chai Discovery announced a collaboration with GSK plc following a successful wet-lab evaluation.

    Source:

  • Oct 8, 2026, 22:00 UTC

    The UK government will invest £33 million through the Dame Barbara Windsor Dementia Goals programme to support dementia research and clinical-trial recruitment.

    Source:

  • Oct 8, 2026, 22:00 UTC

    The UK government will announce a £48 million partnership with healthcare companies and charities to accelerate dementia research and development.

    Source:

  • Oct 8, 2026, 11:38 UTC

    GSK announced a partnership with Viola Davis to launch the “Shingles, actually” educational campaign for adults aged 50 and older.

    Source:

  • Sep 30, 2026, 11:30 UTC

    GSK selected a siRNA program from Wave Life Sciences to transition to GSK for further development, triggering a milestone payment to Wave, with three additional collaboration programs advancing.

    Source:

  • Sep 28, 2026, 08:45 UTC

    A vaccinology training programme was launched on September 25 in Ho Chi Minh City, Vietnam, involving 10 specialities and training units to strengthen preventive healthcare capacity.

    Source:

  • Sep 24, 2026, 12:03 UTC

    GSK announced that its AZUR-1 trial met its primary endpoint, achieving meaningful sustained clinical complete response at 12 months.

    Source:

  • Sep 21, 2026, 20:15 UTC

    AnaptysBio, Inc. reported its financial results for the second quarter and transitional fiscal year ended June 30, 2026, and provided a business update.

    Source:

  • Sep 21, 2026, 10:45 UTC

    Virbac Animal Health India marked 20 years of operations in India, growing from a Rs 100 crore business with about 200 employees to a consolidated turnover of Rs 1,650 crore with more than 1,600 employees.

    Source:

  • Sep 15, 2026, 07:58 UTC

    GSK agreed to acquire global rights to a trispecific T-cell engager from China's Chimagen Biosciences for up to $750 million, with the drug to be developed for multiple myeloma and a Phase I trial planned for 2027.

    Source:

  • Sep 14, 2026, 05:30 UTC

    GSK is providing financial sponsorship for an HKU-led study and investing in shared data infrastructure to use Greater Bay Area patient data for healthcare policy and regulatory evidence.

    Source:

  • Sep 14, 2026, 00:37 UTC

    GlaxoSmithKline announced that its drug Jideytro achieved a 94% objective response rate in previously untreated ROS1-positive non-small cell lung cancer patients in the registrational Phase I/II ARROS-1 trial.

    Source:

  • Sep 10, 2026, 06:45 UTC

    Japan's Ministry of Health, Labour and Welfare approved a prefilled syringe presentation of GSK's Shingrix (Recombinant Zoster Vaccine) for the prevention of shingles.

    Source:

  • Sep 3, 2026, 04:12 UTC

    Hutchison China MediTech and GlaxoSmithKline reached a licensing agreement for a KRAS-EGFR antibody-drug conjugate cancer drug.

    Source:

  • Aug 31, 2026, 11:30 UTC

    Aurobindo Pharma's subsidiary Lannett Company LLC launched a generic version of Advair Diskus in the US market.

    Source:

  • Aug 24, 2026, 12:30 UTC

    The FTSE 100 rose 13 points to 10,830 by midday on 24 August 2026, led by miners and travel stocks, while the FTSE 250 slipped 0.1% to 24,703.

    Source:

  • Aug 24, 2026, 07:06 UTC

    GSK announced that its experimental chronic hepatitis B drug received its first global approval in Japan, and its cancer therapy was granted priority U.S. regulatory review as a possible rectal cancer treatment.

    Source:

  • Aug 21, 2026, 09:30 UTC

    GSK shares dropped 1.72% to 1,887.50p on August 21, 2026.

    Source:

  • Aug 19, 2026, 21:46 UTC

    GSK PLC shares rose 3.4% to $52.88 on August 19, 2026.

    Source:

  • Aug 14, 2026, 11:45 UTC

    The FTSE 100 index traded marginally lower on Friday, with mining stocks declining sharply due to weak metal prices while energy stocks gained on higher oil prices.

    Source:

  • Jul 28, 2026, 11:09 UTC

    GSK reported second-quarter profit that beat expectations on July 28, 2026.

    Source:

  • Jul 28, 2026, 10:17 UTC

    GSK and Hansoh Pharmaceutical announced that their experimental drug Ris-Rez met the primary endpoint of progression-free survival in a late-stage trial for bone cancer.

    Source:
Page 1Next →